COVID-19 vaccines Vaccine safety data Main navigation COVID-19 vaccines Moderna XBB.1.5 COVID-19 vaccine Pfizer XBB.1.5 COVID-19 vaccine Pfizer bivalent BA.4/5 COVID-19 vaccine Moderna bivalent COVID-19 vaccine Pfizer bivalent BA.1 COVID-19 vaccine Pfizer COVID-19 vaccine adult formulation Pfizer COVID-19 vaccine paediatric formulation (5–11 years) Moderna COVID-19 vaccine Novavax COVID-19 vaccine AstraZeneca COVID-19 vaccine Influenza vaccines Mpox (monkeypox) vaccine National Immunisation Program schedule vaccines Nirsevimab RSV vaccines Shingrix® AusVaxSafety is conducting active vaccine safety surveillance of the COVID-19 vaccines in use in Australia to ensure their ongoing safety. The COVID-19 vaccines currently being used are Comirnaty (Pfizer), Spikevax (Moderna) and Nuvaxovid (Novavax). AusVaxSafety is currently reporting safety data on Pfizer, AstraZeneca, Moderna and Novavax COVID-19 vaccines.Latest monthly COVID-19 vaccine safety dataClick on the tiles below to view AusVaxSafety COVID-19 vaccine safety data for specific population groups. Moderna monovalent Omicron XBB.1.5 COVID-19 vaccine safety data – all participants View the latest Moderna XBB.1.5 COVID-19 vaccine safety data here Pfizer monovalent Omicron XBB.1.5 COVID-19 vaccine safety data – all participants View the latest Pfizer XBB.1.5 COVID-19 vaccine safety data here Pfizer bivalent BA.4/5- COVID-19 vaccine View the latest Pfizer bivalent BA.4/5 COVID-19 vaccine safety data here Moderna bivalent COVID-19 vaccine View the latest Moderna bivalent COVID-19 vaccine safety data here Pfizer bivalent BA.1 COVID-19 vaccine View the latest Pfizer bivalent BA.1 COVID-19 vaccine safety data here Pfizer COVID-19 vaccine adult formulation View the latest safety data for Pfizer COVID-19 vaccine adult formulation here Pfizer paediatric (5–11 years) COVID-19 vaccine safety data – child participants View the latest Pfizer paediatric (5–11 years) COVID-19 vaccine safety data here Moderna COVID-19 vaccine View the latest Moderna COVID-19 vaccine safety data here Novavax COVID-19 vaccine View the latest Novavax COVID-19 vaccine safety data here AstraZeneca COVID-19 vaccine View the latest AstraZeneca COVID-19 vaccine safety data here Vaccine safety data Main navigation COVID-19 vaccines Moderna XBB.1.5 COVID-19 vaccine Pfizer XBB.1.5 COVID-19 vaccine Pfizer bivalent BA.4/5 COVID-19 vaccine Moderna bivalent COVID-19 vaccine Pfizer bivalent BA.1 COVID-19 vaccine Pfizer COVID-19 vaccine adult formulation Pfizer COVID-19 vaccine paediatric formulation (5–11 years) Moderna COVID-19 vaccine Novavax COVID-19 vaccine AstraZeneca COVID-19 vaccine Influenza vaccines Mpox (monkeypox) vaccine National Immunisation Program schedule vaccines Nirsevimab RSV vaccines Shingrix® News & events All news & events 02 July 2024 | News Call for participants: new NCIRS study on possible links between genes and adverse events after COVID-19 vaccination 28 March 2024 | News AusVaxSafety commences routine surveillance of 2024 seasonal influenza vaccines 08 March 2024 | News Vaccine safety in Australia AusVaxSafety summary report now available 20 February 2024 | News What to expect in the days after your XBB.1.5 COVID-19 vaccine